Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1040/week)
Manufacturing
(498/week)
Technology
(1030/week)
Energy
(412/week)
Other Manufacturing
(310/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Elysium Health
Mar 13, 2025
Elysium Health(TM) Announces the Launch of COFACTOR(TM): An advanced 4-in-1 Collagen System With NAD+ Boost
Dec 10, 2024
New Research by Elysium Health and University of Oxford Reveals Link Between Naturally Occurring Amino Acid and Accelerated Aging
Oct 16, 2024
Elysium Health(TM) Announces the Launch of VISION(TM) for Eye Longevity, Performance, and Protection
Jun 12, 2024
Natural Compounds Found in Milk and Blueberries Synergistically Provide Protective Benefits Against UV Exposure
Jun 15, 2020
Elysium Health(TM) Announces the Launch of MATTER(TM)
Apr 23, 2020
Elysium Health(TM) Announces Exclusive License of DNA Methylation Biomarkers of Personalized Health and Aging and Cellular Senescence from Yale University
Jan 27, 2020
National Advertising Division Finds that Certain Cellular Health Claims for Basis Dietary Supplement are Supported
Jan 09, 2020
Elysium Health(TM) Announces Clinical Trial to Study Correlations Between Epigenetic Aging and Nicotinamide Adenine Dinucleotide (NAD+) Levels in Healthy Adults
Dec 23, 2019
Elysium Health(TM) Announces $40 Million Series C Financing Led by GISEV Family Office
Nov 21, 2019
Elysium Health(TM) Announces Clinical Trial to Explore the Effect of Basis(TM) on Liver Fat Accumulation in Healthy Adults with Fatty Liver (NAFL)
Aug 09, 2019
Elysium Health(TM) Announces Initiation of Clinical Trial to Explore the Effects of Basis(TM) and High-Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance
Sep 19, 2018
Elysium Health(TM) Responds to Baseless Allegations by Disgruntled Former Supplier
Aug 16, 2018
Elysium Health(TM) Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
Mar 29, 2018
Elysium Health(TM) Granted Orphan Drug Designation for EH301 to Treat Amyotrophic Lateral Sclerosis (ALS)
Feb 01, 2018
Elysium Health(TM) and University of Oxford Name First Prize Fellowship Recipient Who Will Study Aging and Cellular Health
Nov 27, 2017
Elysium Health(TM) Announces Positive Data on Its Product BASIS Published in "Nature Partner Journals: Aging and Mechanisms of Disease"
Latest News
Aug 28, 2025
Toshiba Releases 650V 3rd Generation SiC MOSFETs in TOLL Package
Aug 28, 2025
USA Compression Partners, LP Announces Upsized Credit Facility
Aug 28, 2025
Macron et Merz vont sceller le "reset" franco-allemand à Brégançon
Aug 28, 2025
China says North Korea's Kim Jong Un to attend September 3 parade
Aug 28, 2025
Qantas says profits up, strong travel demand ahead
Aug 28, 2025
ATS to Participate in the Morgan Stanley 13th Annual Laguna Conference
Aug 28, 2025
Redwire to Present at Jefferies Industrials Conference on September 3, 2025
Aug 28, 2025
Fortive Declares Regular Quarterly Dividend on its Common Stock
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events